129 related articles for article (PubMed ID: 36569524)
1. Efficacy and Tolerability of HydraFacial Clarifying Treatment Series in the Treatment of Active Acne Vulgaris.
Storgard R; Mauricio-Lee J; Mauricio T; Zaiac M; Karnik J
J Clin Aesthet Dermatol; 2022 Dec; 15(12):42-46. PubMed ID: 36569524
[TBL] [Abstract][Full Text] [Related]
2. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
Stein Gold L; Pariser DM; Guenin E
J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.
Bertolani MB; Rodighiero E; Gandolfi M; Lotti T; Pedrazzi G; Puviani M; Milani M; Feliciani C; Satolli F
Dermatol Ther; 2021 Jan; 34(1):e14724. PubMed ID: 33377285
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
Harper JC; Baldwin H; Stein Gold L; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study.
Shah BJ; Sumathy TK; Dhurat RS; Torsekar RG; Viswanath V; Mukhi JI; Kadhe G; Ahirrao P
Indian J Dermatol; 2014 Jul; 59(4):385-9. PubMed ID: 25071260
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system.
Wheeland RG; Dhawan S
J Drugs Dermatol; 2011 Jun; 10(6):596-602. PubMed ID: 21637900
[TBL] [Abstract][Full Text] [Related]
8. Combined 400-600nm and 800-1200nm Intense Pulsed Phototherapy of Facial Acne Vulgaris.
Knight JM
J Drugs Dermatol; 2019 Nov; 18(11):1116-1122. PubMed ID: 31741354
[TBL] [Abstract][Full Text] [Related]
9. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Tolerability of a Combined 445nm and 630nm Over-the-counter Light Therapy Mask with and without Topical Salicylic Acid versus Topical Benzoyl Peroxide for the Treatment of Mild-to-moderate Acne Vulgaris.
Nestor MS; Swenson N; Macri A; Manway M; Paparone P
J Clin Aesthet Dermatol; 2016 Mar; 9(3):25-35. PubMed ID: 27354885
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study.
Serini SM; Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Ventura A; Milani M; Campione E; Bianchi L
J Cosmet Dermatol; 2019 Feb; 18(1):156-162. PubMed ID: 29790262
[TBL] [Abstract][Full Text] [Related]
12. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population.
Eichenfield LF; Sugarman JL; Guenin E; Harris S; Bhatt V
Pediatr Dermatol; 2019 Mar; 36(2):193-199. PubMed ID: 30656753
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris.
Ammad S; Gonzales M; Edwards C; Finlay AY; Mills C
J Cosmet Dermatol; 2008 Sep; 7(3):180-8. PubMed ID: 18789052
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study.
Villani A; Annunziata MC; Cinelli E; Donnarumma M; Milani M; Fabbrocini G
G Ital Dermatol Venereol; 2020 Oct; 155(5):676-679. PubMed ID: 32869963
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Amar L; Kircik LH
J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
[TBL] [Abstract][Full Text] [Related]
16. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
Cook-Bolden FE; Gold MH; Guenin E
J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
18. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
Lain E; Day D; Harper J; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
[TBL] [Abstract][Full Text] [Related]
19. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
Tanghetti EA; Kircik LH; Green LJ; Guenin E; Harris S; Martin G; Pillai R
J Drugs Dermatol; 2019 Jun; 18(6):542. PubMed ID: 31251546
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.
Thiboutot DM; Kircik L; McMichael A; Cook-Bolden FE; Tyring SK; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
J Clin Aesthet Dermatol; 2016 Oct; 9(10):18-27. PubMed ID: 27847545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
